SEBI Reg. Investment Advisor

Download App

Help Center Subscribe

Recent:

BSE Healthcare Companies

BSE Sensex 76808.48
544.15 (0.71%)

The BSE Healthcare Index is designed to reflect the behaviour and performance of mid market capitalization companies. S&P BSE Mid Cap includes all companies forming part of mid cap universe on BSE. Look for Green and Orange companies for investing. Bookmark this page for your easy reference in future.

See MoneyWorks4me's rating on Quality, Valuation, Price Trend and Overall Rating to take informed stock investing decisions. Decizen :- Q: Quality, V: Valuation, PT: Price Trend

Filter

BSE Healthcare companies as on Jun-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	CMP	Price Change (%)	Market Cap (Cr)	52Week High	52Week Low	ROE(%)	P/E	P/BV	EV/ EBITDA	5Y Sales Gr.(%)	5Y Profit Gr.(%)
1	Tarsons Products Ltd	Q V+ PT	239	15.64%	1,100 Small Cap	406 17 Jun, 25	164 30 Mar, 26	5.71	48.56	1.63	9.82	12.30	-1.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	Orchid Pharma Ltd	Q V PT	1,044	8.71%	4,872 Small Cap	961 15 Jun, 26	471 30 Mar, 26	8.04	107.77	3.56	49.57	13.89	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	Fabtech Technologies Ltd	Q V PT	158	8.20%	651 Small Cap	262 28 Oct, 25	126 02 Mar, 26	15.06	26.83	1.67	11.64	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
4	Anuh Pharma Ltd	Q V PT	81.44	4.72%	779 Small Cap	115 08 Jul, 25	66.72 30 Mar, 26	15.31	18.99	2.21	11.67	16.60	20.73	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
5	Nephrocare Health Services Ltd	Q V+ PT	743	4.47%	7,133 Small Cap	768 12 Jun, 26	445 19 Dec, 25	7.15	0.00	7.35	66.70	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
6	Shilpa Medicare Ltd	Q V+ PT	554	4.11%	10,411 Small Cap	581 10 Jun, 26	260 27 Jan, 26	4.25	42.78	4.02	24.80	7.22	-12.54	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
7	Sun Pharma Advanced Research Company Ltd	Q V+ PT	238	3.99%	7,441 Small Cap	249 26 May, 26	108 23 Mar, 26	719.99	4.79	5.58	4.97	-1.35	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
8	Glaxosmithkline Pharmaceuticals Ltd	Q V PT	2,201	3.60%	35,993 Mid Cap	3,500 27 Jun, 25	2,088 12 Jun, 26	45.95	34.74	15.76	23.79	5.49	17.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
9	Bliss GVS Pharma Ltd	Q V+ PT	453	3.10%	4,663 Small Cap	463 04 Jun, 26	118 10 Nov, 25	5.40	48.14	4.04	25.47	8.59	-5.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
10	Gufic Biosciences Ltd	Q V PT	370	2.73%	3,612 Small Cap	409 01 Aug, 25	268 30 Mar, 26	12.60	57.20	5.44	25.65	16.69	24.75	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
11	Novartis India Ltd	Q V+ PT	1,321	2.03%	3,198 Small Cap	1,588 01 Jun, 26	750 21 Jan, 26	13.21	34.32	3.91	19.04	-4.06	54.56	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
12	Health X Platform Ltd	Q V PT	305	1.94%	951 Small Cap	375 13 Jan, 26	253 30 Mar, 26	-0.26	0.00	3.51	-1189.71	109.54	-201.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
13	Unichem Laboratories Ltd	Q V PT	448	1.84%	3,098 Small Cap	657 16 Jul, 25	280 30 Mar, 26	5.91	19.49	1.19	25.55	13.92	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
14	Emcure Pharmaceuticals Ltd	Q V PT	1,736	1.84%	32,327 Small Cap	1,830 05 May, 26	1,230 07 Jul, 25	11.03	44.11	8.71	25.24	13.02	9.98	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
15	Sanofi India Ltd	Q V PT	3,306	1.79%	7,480 Small Cap	6,400 01 Jul, 25	3,058 29 May, 26	42.80	24.15	9.59	14.92	-8.74	-7.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
16	Hikal Ltd	Q V+ PT	190	1.71%	2,303 Small Cap	382 17 Jun, 25	146 30 Mar, 26	7.16	0.00	1.92	12.76	4.29	-1.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
17	Metropolis Healthcare Ltd	Q V PT	534	1.62%	10,894 Small Cap	600 14 May, 26	413 02 Apr, 26	11.92	57.33	7.20	25.45	9.22	2.10	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
18	Divis Laboratories Ltd	Q V PT	6,713	1.59%	1,75,426 Large Cap	7,078 08 Jul, 25	5,638 29 Sep, 25	15.14	68.31	10.47	43.57	11.65	10.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
19	Strides Pharma Science Ltd	Q V+ PT	1,102	1.56%	10,004 Small Cap	1,231 12 May, 26	770 29 Jan, 26	1.56	54.48	3.05	27.23	4.81	-16.98	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
20	Global Health Ltd	Q V PT	1,236	1.51%	32,724 Small Cap	1,456 08 Aug, 25	955 30 Mar, 26	15.18	65.95	8.14	37.28	16.83	34.86	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
21	Panacea Biotec Ltd	Q V+ PT	549	1.44%	3,315 Small Cap	648 09 Jun, 26	293 30 Mar, 26	-4.99	0.00	11.62	17857.92	-8.75	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
22	Cohance Lifesciences Ltd	Q V+ PT	432	1.37%	16,315 Small Cap	1,121 17 Jul, 25	268 09 Mar, 26	13.87	91.03	4.17	35.62	7.51	-3.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
23	Dr. Lal Pathlabs Ltd	Q V PT	1,641	1.35%	27,136 Small Cap	1,771 19 Sep, 25	1,272 23 Mar, 26	25.35	53.40	10.97	30.35	13.05	17.98	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
24	Jupiter Life Line Hospitals Ltd	Q V PT	1,341	1.25%	8,686 Small Cap	1,618 31 Oct, 25	1,152 02 Mar, 26	13.61	45.38	5.40	26.01	18.02	36.61	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
25	Bajaj Healthcare Ltd	Q V+ PT	303	1.19%	1,007 Small Cap	553 15 Jul, 25	272 18 May, 26	9.19	47.24	1.89	10.74	5.76	2.91	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
26	CORONA Remedies Ltd	Q V+ PT	1,748	1.18%	10,565 Small Cap	1,951 12 May, 26	1,337 23 Dec, 25	27.46	57.15	14.16	35.07	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
27	Blue Jet Healthcare Ltd	Q V PT	510	1.14%	8,750 Small Cap	1,028 21 Jul, 25	325 30 Mar, 26	28.99	35.31	6.43	23.71	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
28	Alembic Pharmaceuticals Ltd	Q V+ PT	747	1.14%	14,518 Small Cap	1,108 30 Jun, 25	635 23 Mar, 26	11.08	21.52	2.56	13.37	7.69	-8.97	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
29	Innova Captab Ltd	Q V PT	959	1.11%	5,430 Small Cap	1,003 13 Jun, 25	608 02 Mar, 26	9.48	64.88	6.12	34.92	25.90	14.68	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
30	Vijaya Diagnostic Centre Ltd	Q V+ PT	1,298	1.09%	13,211 Small Cap	1,425 05 Jun, 26	848 30 Mar, 26	19.78	76.38	13.80	36.78	15.00	18.43	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
31	Kwality Pharmaceuticals Ltd	Q V+ PT	2,428	0.97%	2,495 Small Cap	2,600 10 Jun, 26	829 11 Nov, 25	16.19	37.05	7.50	21.66	21.70	37.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
32	Astrazeneca Pharma India Ltd	Q V+ PT	8,500	0.88%	21,063 Small Cap	10,653 13 Jun, 25	7,630 06 Apr, 26	24.76	112.32	24.13	70.96	15.59	20.47	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
33	Krishna Institute of Medical Sciences Ltd	Q V+ PT	778	0.88%	30,865 Small Cap	810 08 Jun, 26	576 27 Jan, 26	14.20	118.39	12.71	61.56	11.87	17.04	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
34	Rubicon Research Ltd	Q V+ PT	1,355	0.87%	22,216 Small Cap	1,372 02 Jun, 26	571 24 Oct, 25	28.27	118.07	16.42	69.13	32.49	25.95	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
35	Windlas Biotech Ltd	Q V PT	826	0.84%	1,690 Small Cap	1,095 19 Aug, 25	699 16 Mar, 26	12.61	25.44	3.17	14.02	18.24	17.22	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
36	Sanofi Consumer Healthcare India Ltd	Q V+ PT	4,743	0.78%	10,839 Small Cap	5,954 30 Jun, 25	3,951 02 Mar, 26	71.09	42.03	23.99	29.68	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
37	Wockhardt Ltd	Q V+ PT	1,922	0.74%	30,999 Small Cap	2,420 01 Jun, 26	1,087 23 Mar, 26	-1.15	145.53	6.27	43.08	1.15	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
38	Ajanta Pharma Ltd	Q V PT	3,078	0.64%	38,215 Mid Cap	3,315 19 May, 26	2,335 30 Sep, 25	24.45	36.19	8.44	24.46	12.43	17.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
39	Caplin Point Laboratories Ltd	Q V PT	2,378	0.60%	17,967 Small Cap	2,424 12 Jun, 26	1,502 30 Mar, 26	20.20	28.02	5.01	19.79	17.55	21.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
40	Suraksha Diagnostic Ltd	Q V PT	269	0.60%	1,395 Small Cap	354 26 Jun, 25	224 30 Mar, 26	16.38	43.33	5.70	13.90	9.86	-51.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
41	Laxmi Dental Ltd	Q V PT	228	0.57%	1,244 Small Cap	510 21 Jul, 25	156 30 Mar, 26	8.81	75.73	5.04	32.25	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
42	GPT Healthcare Ltd	Q V PT	148	0.51%	1,208 Small Cap	185 01 Aug, 25	114 30 Mar, 26	21.30	28.62	4.48	13.53	13.96	24.04	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
43	Natco Pharma Ltd	Q V+ PT	852	0.47%	15,180 Small Cap	1,226 12 May, 26	789 30 Sep, 25	26.69	10.70	1.65	8.27	18.26	32.57	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
44	Advanced Enzyme Technologies Ltd	Q V PT	368	0.45%	4,104 Small Cap	420 11 May, 26	252 30 Mar, 26	16.84	31.14	5.78	23.60	7.28	11.87	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
45	Indegene Ltd	Q V+ PT	516	0.42%	12,375 Small Cap	610 13 Jun, 25	415 23 Mar, 26	19.78	30.85	3.94	17.36	34.59	31.10	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
46	Kovai Medical Center & Hospital Ltd	Q V PT	5,791	0.35%	6,314 Small Cap	6,725 27 Oct, 25	5,010 30 Mar, 26	21.22	25.83	4.79	13.57	14.01	17.17	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
47	Rainbow Childrens Medicare Ltd	Q V PT	1,422	0.28%	14,400 Small Cap	1,644 24 Jul, 25	1,009 02 Mar, 26	17.13	57.60	8.53	26.47	15.91	24.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
48	Alkem Laboratories Ltd	Q V+ PT	5,349	0.24%	63,809 Mid Cap	5,933 13 Jan, 26	4,717 10 Jul, 25	17.86	29.20	4.56	21.16	5.71	10.33	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
49	Poly Medicure Ltd	Q V PT	1,516	0.21%	15,330 Small Cap	2,318 02 Jul, 25	1,184 30 Mar, 26	15.04	45.63	5.02	27.45	19.91	26.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
50	Suven Life Sciences Ltd	Q V+ PT	270	0.20%	7,113 Small Cap	303 16 Jul, 25	124 24 Mar, 26	-6.13	0.00	4.73	-138.13	-14.30	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Tarsons Products	239.15	15.64%
Orchid Pharma	1,044.30	8.71%
Fabtech Technologies	158.40	8.20%
Anuh Pharma	81.44	4.72%
Nephrocare Health Se	742.60	4.47%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
IOL Chem & Pharma	126.10	-5.54%
Akums Drugs & Pharma	595.65	-3.98%
Fischer Medical	34.52	-3.14%
Acutaas Chemicals	2,999.40	-3.06%
Indoco Remedies	233.10	-2.59%

News about BSE Healthcare

Jun, 2026

Krishna Institute of Medical Sciences informs about outcome of board meeting

Krishna Institute of Medical Sciences has informed that the Board of Directors at its meeting held on Friday, May 15 2026, considered and approved, the audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended 31st March 2026. In furtherance to the aforesaid intimation, please find enclosed the audited Standalone and Consolidated Financial Statements of the Company for the year ended 31st March 2026, along with the audit reports issued thereon by the Statutory Auditors.

The above information is a part of company’s filings submitted to BSE.

Jun, 2026

Panacea Biotec informs about newspaper publication

Panacea Biotec has informed that it enclosed newspaper copies regarding notice intimating the investors about the opening of a Special Window for Transfer and Dematerialization of physical shares, in accordance with SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated January 30, 2026, published on June 16, 2026, in the newspapers: Financial Express; and Desh Sewak (Punjabi).

The above information is a part of company’s filings submitted to BSE.

Jun, 2026

Suven Life Sciences informs about press release

Suven Life Sciences has informed that it enclosed News Release of the company titled ‘Suven Life Sciences announces successful completion and topline results of First-in-Human (FIH) Phase-1 clinical study of SUVN-I6107, a Muscarinic M1 Positive Allosteric Modulator (M1-PAM) and its advancement into Phase-2 clinical development’.

The above information is a part of company’s filings submitted to BSE.

Jun, 2026

Corona Remedies informs about AGM

Corona Remedies has informed that the 22nd Annual General Meeting (AGM) of the Company is scheduled to be held on Thursday, July 09, 2026 at 11:00 am through Video Conferencing (VC) / Other Audio Visual Means (OAVM) in accordance with the applicable circulars issued by the Ministry of Corporate Affairs and Securities and Exchange Board of India.

The above information is a part of company’s filings submitted to BSE.

Jun, 2026

Fabtech Technologies secures contract worth Rs 31.23 crore

The contract is for the critical internal infrastructure scope of a new Veterinary Vaccine Manufacturing Facility in Botswana

Jun, 2026

Fabtech Technologies informs about new order

Fabtech Technologies has informed that the Company has secured an order/contract from Botswana Vaccine Institute. The details required under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular No. SEBI/ HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are attached as ‘Annexure A’.

The above information is a part of company’s filings submitted to BSE.

Track Now:

5 Star Companies Large Cap Companies Mid Cap Companies Small Cap Companies Nifty Microcap Companies Top IT Companies Tax saver funds Analyze your Equity Funds Nifty Index Funds

BSE Healthcare FAQs

You can use different criterias to arrive at the list of best stocks in the BSE Healthcare company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the BSE Healthcare companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Sun Pharma Advanced Research Company Ltd. (S)	Not Good	238	7,441	4.79	5.58	4.97	720
Sanofi Consumer Healthcare India Ltd. (S)	Not Good	4,743	10,839	42.03	23.99	29.68	71.09
Wanbury Ltd. (S)	Very Good	267	933	14.11	6.46	10.60	69.35
Glaxosmithkline Pharmaceuticals Ltd. (M)	Very Good	2,201	35,993	34.74	15.76	23.79	45.95
Procter & Gamble Health Ltd. (S)	Very Good	6,219	10,353	31.67	19.74	21.45	43.64

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,376	75,057	108
Sai Life Sciences Ltd. (S)	Very Good	1,207	25,667	56.96
Granules India Ltd. (S)	Very Good	749	18,561	47.03
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,465	1,52,603	38.70
Aster DM Healthcare Ltd. (S)	Somewhat Good	780	40,815	38.24
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Health X Platform Ltd. (S)	Not Good	305	951	0.00	3.51	-1189.71	110
Fischer Medical Ventures Ltd. (S)	Not Good	34.52	2,333	0.00	7.47	-453.05	96.10
3B Blackbio Dx Ltd. (S)	Somewhat Good	1,265	1,101	22.33	4.04	15.17	46.29
Max Healthcare Institute Ltd. (M)	N/A	1,024	1,00,142	69.43	9.32	42.55	46.01
Indegene Ltd. (S)	Very Good	516	12,375	30.85	3.94	17.36	34.59

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Yatharth Hospital & Trauma Care Services Ltd. (S)	Very Good	827	7,996	83.81	4.94	49.08	138
3B Blackbio Dx Ltd. (S)	Somewhat Good	1,265	1,101	22.33	4.04	15.17	132
Neuland Laboratories Ltd. (S)	Somewhat Good	16,714	21,874	60.24	11.73	35.99	64.99
Max Healthcare Institute Ltd. (M)	N/A	1,024	1,00,142	69.43	9.32	42.55	60.18
Novartis India Ltd. (S)	Somewhat Good	1,321	3,198	34.32	3.91	19.04	54.56

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

BSE Healthcare Companies

News about BSE Healthcare

Krishna Institute of Medical Sciences informs about outcome of board meeting

Panacea Biotec informs about newspaper publication

Suven Life Sciences informs about press release

Corona Remedies informs about AGM

Fabtech Technologies secures contract worth Rs 31.23 crore

Fabtech Technologies informs about new order

Track Now:

Trending Blogs

BSE Healthcare FAQs

How to select the top BSE Healthcare stocks based on RoE?

What are the best-performing stocks in the BSE Healthcare index?

Which BSE Healthcare stocks have the highest revenue growth in the past five years?

Which BSE Healthcare stocks had the highest profit growth in the past five years ?

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.